129 related articles for article (PubMed ID: 22923000)
1. Could spindle cell lung carcinoma be considered and treated as sarcoma, according to its clinical course, morphology, immunophenotype and genetic finding?
Kontic M; Stojsic J; Stevic R; Bunjevacki V; Jekić B; Dobricic V
Pathol Oncol Res; 2013 Jan; 19(1):129-33. PubMed ID: 22923000
[TBL] [Abstract][Full Text] [Related]
2. Alteration of the p53 gene of lung carcinomas with sarcomatous transformation (spindle cell carcinoma): analysis of four cases.
Kawano R; Takeshima Y; Inai K
Pathol Int; 1996 Jan; 46(1):38-45. PubMed ID: 10846548
[TBL] [Abstract][Full Text] [Related]
3. Sarcomatous transformation of EGFR and TP53 mutation-positive metastatic adenocarcinoma of the lungs, masquerading as a primary pleomorphic sarcoma of the proximal femur.
Toda-Ishii M; Akaike K; Kurisaki-Arakawa A; Arakawa A; Mukaihara K; Suehara Y; Takagi T; Kaneko K; Yao T; Saito T
Int J Clin Exp Pathol; 2015; 8(3):3270-8. PubMed ID: 26045851
[TBL] [Abstract][Full Text] [Related]
4. Morphologic diversity of malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma based on the study of 24 cases, sporadic or occurring in the setting of Brooke-Spiegler syndrome.
Kazakov DV; Zelger B; Rütten A; Vazmitel M; Spagnolo DV; Kacerovska D; Vanecek T; Grossmann P; Sima R; Grayson W; Calonje E; Koren J; Mukensnabl P; Danis D; Michal M
Am J Surg Pathol; 2009 May; 33(5):705-19. PubMed ID: 19194280
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary Sarcomatoid Carcinomas: A Review.
Weissferdt A
Adv Anat Pathol; 2018 Sep; 25(5):304-313. PubMed ID: 29912718
[TBL] [Abstract][Full Text] [Related]
6. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
[TBL] [Abstract][Full Text] [Related]
7. p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components.
Lien HC; Lin CW; Mao TL; Kuo SH; Hsiao CH; Huang CS
J Pathol; 2004 Oct; 204(2):131-9. PubMed ID: 15376261
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival in a patient with pulmonary spindle cell carcinoma treated with traditional Chinese medicine.
Li W; Chen M; Zhao Y
BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30196260
[TBL] [Abstract][Full Text] [Related]
9. Molecular assessment of clonality leads to the identification of a new germ line TP53 mutation associated with malignant cystosarcoma phyllodes and soft tissue sarcoma.
Bot FJ; Sleddens HF; Dinjens WN
Diagn Mol Pathol; 1998 Dec; 7(6):295-301. PubMed ID: 10207667
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic and molecular genetic characterizations of biphenotypic sinonasal sarcoma].
Zhao M; Weng LaoI; Zhao DH; Ma J; Ru GQ; He XL; Wang Z; Wang J
Zhonghua Bing Li Xue Za Zhi; 2017 Dec; 46(12):841-846. PubMed ID: 29224278
[No Abstract] [Full Text] [Related]
11. [Clinicopathologic features of lung pleomorphic (spindle/giant cell) carcinoma--a report of 17 cases].
Zhao ZL; Song N; Huang QY; Liu YP; Zhao HR
Ai Zheng; 2007 Feb; 26(2):183-8. PubMed ID: 17298750
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of the tumor volume doubling time on sarcoma patients with lung metastases.
Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
Clin Exp Metastasis; 2011 Dec; 28(8):819-25. PubMed ID: 21805254
[TBL] [Abstract][Full Text] [Related]
13. p53 gene mutations and p53 protein expression in human soft tissue sarcomas.
Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI
Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310
[TBL] [Abstract][Full Text] [Related]
14. EGFR and p53 status of pulmonary pleomorphic carcinoma: implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy.
Chang YL; Wu CT; Shih JY; Lee YC
Ann Surg Oncol; 2011 Oct; 18(10):2952-60. PubMed ID: 21409490
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of p53 exon 4 mutations in soft tissue sarcoma.
Das P; Kotilingam D; Korchin B; Liu J; Yu D; Lazar AJ; Pollock RE; Lev D
Cancer; 2007 Jun; 109(11):2323-33. PubMed ID: 17429838
[TBL] [Abstract][Full Text] [Related]
16. Pleomorphic carcinoma of the lung associated with loss of heterozygosity of p53 gene.
Arita N; Mikami Y; Yoshida M; Konishi I; Horiike N; Miyauchi K; Miyazaki T; Nose M; Ono M
Tohoku J Exp Med; 2005 Jun; 206(2):181-5. PubMed ID: 15888975
[TBL] [Abstract][Full Text] [Related]
17. p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implications for histogenesis.
Holst VA; Finkelstein S; Colby TV; Myers JL; Yousem SA
Am J Surg Pathol; 1997 Jul; 21(7):801-11. PubMed ID: 9236836
[TBL] [Abstract][Full Text] [Related]
18. Investigation on the Genomic Characterization of Uterine Sarcoma for rAd-
Xia Y; Wang L; Ma X; Li X
Hum Gene Ther; 2020 Aug; 31(15-16):881-890. PubMed ID: 32013587
[TBL] [Abstract][Full Text] [Related]
19. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M
J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354
[TBL] [Abstract][Full Text] [Related]
20. p53 gene mutations in soft-tissue sarcomas--correlations with p53 immunohistochemistry and DNA ploidy.
Schneider-Stock R; Radig K; Oda Y; Mellin W; Rys J; Niezabitowski A; Roessner A
J Cancer Res Clin Oncol; 1997; 123(4):211-8. PubMed ID: 9177493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]